Dynamic and results-driven Process Scientist with 14+ years of global experience in drug discovery, process development, and commercialization across CMO/CDMO environments. Proven expertise in organic synthesis, route scouting, and scale-up (mg to multi-kg/plant scale) supporting Phase I–III clinical programs, NCEs, and CRAMS projects. Extensive experience in PROTACs, TPD glue degraders, oncology therapeutics, and small molecules.

Recognized for leading large multidisciplinary teams (10–22 FTEs), direct client engagement, and delivering high-quality outcomes through cost-effective process optimization, technology transfer, and robust development strategies. Strong track record in managing FTE/FFS models, RFQs, SAP-based operations, and regulatory-compliant laboratory practices. Adept at SAR interpretation, analogue design, impurity profiling, and analytical data interpretation (NMR, LC-MS, HPLC).

Authored 12+ peer-reviewed publications in leading international journals and 3 granted patents. Holds a Ph.D. in Organic Chemistry, post-doctoral training from KRICT (Korea), and an MBA in Pharmaceutical & Leadership Management. Passionate about enabling efficient, scalable, and innovative solutions for drug development and commercialization.